Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person CA1:Zn2+,CA2:Zn2+ bind CA inhibitors

Class:Id	Reaction:9707419
_displayName	CA1:Zn2+,CA2:Zn2+ bind CA inhibitors
_doRelease	TRUE
_timestamp	2022-05-10 17:54:53
authored	[InstanceEdit:9724665] Jassal, Bijay, 2021-03-25
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9707445] Jassal, Bijay, 2020-11-19
edited	[InstanceEdit:9757169] Jassal, Bijay, 2021-10-27 [InstanceEdit:9773839] Matthews, Lisa, 2022-05-10
input	[DefinedSet:9707420] CA inhibitors [cytosol] [DefinedSet:1475437] CA1:Zn2+,CA2:Zn2+ [cytosol] [Homo sapiens]
isChimeric	FALSE
literatureReference	[LiteratureReference:9707427] Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension [LiteratureReference:9707418] Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro [LiteratureReference:9707454] The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor [LiteratureReference:9707435] Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension [LiteratureReference:9707461] Carbonic anhydrase inhibition by acetazolamide reduces in vitro epileptiform synchronization
modified	[InstanceEdit:9773229] Matthews, Lisa, 2022-05-03 [InstanceEdit:9773839] Matthews, Lisa, 2022-05-10 [InstanceEdit:9773858] Matthews, Lisa, 2022-05-10 [InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
name	CA1:Zn2+,CA2:Zn2+ bind CA inhibitors
output	[Complex:9707410] CA1:Zn2+,CA2:Zn2+:CA inhibitors [cytosol] [Homo sapiens]
releaseDate	2022-06-09
reviewed	[InstanceEdit:9767610] Huddart, Rachel, 2022-03-01
reviewStatus	[ReviewStatus:9821382] five stars
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9707467] R-HSA-9707419.2
summation	[Summation:9707428] Erythrocytes take up oxygen and release carbon dioxide in th...
(hasEvent)	[Pathway:1237044] Erythrocytes take up carbon dioxide and release oxygen [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by CA1:Zn2+,CA2:Zn2+ bind CA inhibitors (9707419)